Article
Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4: an examination of the extent and potential implications.
Pharmacogenetics and genomics - 1 Jun 2016
Creemer Olivia J, Ansari-Pour Naser, Ekong Rosemary, Tarekegn Ayele, Plaster Christopher, Bains Ripudaman K, Itan Yuval, Bekele Endashaw, Bradman Neil
Abstract excerpt
OBJECTIVE: CYP3A4 expression varies up to 100-fold among individuals, and, to date, genetic causes remain elusive. As a major drug-metabolizing enzyme, elucidation of such genetic causes would increase the potential for introducing personalized dose adjustment of therapies involving CYP3A4 drug substrates. The foetal CYP3A isoform, CYP3A7, is reported to be expressed in ∼10% of European adults and may thus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
